We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
Cap. Flow
-$21B
Cap. Flow %
-11.12%
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388

Sector Composition

Rank Sector Weight
1 Technology 14.66%
2 Healthcare 11.06%
3 Financials 8.17%
4 Consumer Discretionary 8.09%
5 Communication Services 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBN icon
1826
ICICI Bank
IBN
$109B
$6.63M ﹤0.01%
384,318
-138,792
-27% -$2.31M
BTG icon
1827
B2Gold
BTG
$5.22B
$6.62M ﹤0.01%
1,572,055
-576,964
-27% -$2.82M
TAP icon
1828
PUT
Molson Coors Class B
TAP
$7.91B
$6.61M ﹤0.01%
+121,400
New +$6.78M
HUM icon
1829
CALL
Humana
HUM
$43.8B
$6.59M ﹤0.01%
14,900
+14,300
+2,383% +$6.25M
PNFP icon
1830
Pinnacle Financial Partners Inc
PNFP
$16.6B
$6.58M ﹤0.01%
74,476
-19,824
-21% -$1.77M
CLDR
1831
DELISTED
Cloudera, Inc.
CLDR
$6.57M ﹤0.01%
416,240
+94,332
+29% +$1.28M
WTRE
1832
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
$6.56M ﹤0.01%
187,430
+3,593
+2% +$125K
PACK icon
1833
Ranpak Holdings
PACK
$487M
$6.56M ﹤0.01%
270,553
+10,912
+4% +$229K
CNXC icon
1834
Concentrix
CNXC
$1.54B
$6.55M ﹤0.01%
40,755
-6,812
-14% -$1.05M
IBB icon
1835
PUT
iShares Biotechnology ETF
IBB
$9.36B
$6.55M ﹤0.01%
40,000
+19,900
+99% +$3.07M
PEGA icon
1836
Pegasystems
PEGA
$5.2B
$6.54M ﹤0.01%
93,944
+8,466
+10% +$534K
BXP icon
1837
CALL
Boston Properties
BXP
$11.2B
$6.53M ﹤0.01%
57,400
+23,800
+71% +$2.67M
CRNC icon
1838
Cerence
CRNC
$417M
$6.53M ﹤0.01%
61,222
-16,479
-21% -$1.62M
SLAB icon
1839
Silicon Laboratories
SLAB
$7.19B
$6.53M ﹤0.01%
42,620
-38,167
-47% -$5.34M
ARKK icon
1840
CALL
ARK Innovation ETF
ARKK
$6.09B
$6.53M ﹤0.01%
49,900
+1,300
+3% +$152K
ILF icon
1841
iShares Latin America 40 ETF
ILF
$3.83B
$6.53M ﹤0.01%
207,050
+58,196
+39% +$1.74M
TTM
1842
DELISTED
Tata Motors Limited
TTM
$6.52M ﹤0.01%
285,756
-397,597
-58% -$8.53M
MAC icon
1843
Macerich
MAC
$7.25B
$6.5M ﹤0.01%
354,173
+56,858
+19% +$852K
IRBT
1844
PUT
DELISTED
iRobot
IRBT
$6.48M ﹤0.01%
69,400
-65,700
-49% -$6.74M
LTPZ icon
1845
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$719M
$6.48M ﹤0.01%
+75,000
New +$6.24M
TXNM
1846
TXNM Energy Inc
TXNM
$5.94B
$6.48M ﹤0.01%
132,895
-65,744
-33% -$3.23M
MCS icon
1847
Marcus Corp
MCS
$949M
$6.47M ﹤0.01%
311,984
+6,213
+2% +$129K
RTX icon
1848
PUT
RTX Corp
RTX
$294B
$6.47M ﹤0.01%
76,600
-77,200
-50% -$6.5M
LHCG
1849
DELISTED
LHC Group LLC
LHCG
$6.46M ﹤0.01%
32,258
+413
+1% +$82.8K
STL
1850
DELISTED
Sterling Bancorp
STL
$6.45M ﹤0.01%
261,545
+52,163
+25% +$1.31M

Similar funds

Credit Suisse's Q2 2021 Portfolio in Review

As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.

  • Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
  • Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
  • Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
  • Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
  • Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
  • Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
  • Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.